GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Total Long-Term Liabilities

ImmuPharma (LSE:IMM) Total Long-Term Liabilities : £0.00 Mil (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. ImmuPharma's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was £0.00 Mil.

ImmuPharma Total Long-Term Liabilities Historical Data

The historical data trend for ImmuPharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuPharma Total Long-Term Liabilities Chart

ImmuPharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ImmuPharma Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ImmuPharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

ImmuPharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of ImmuPharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuPharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Total Long-Term Liabilities
Comparable Companies
LSE:IXI LSE:POLB AQSE:PBX LSE:OPTI LSE:APTA LSE:CIZ LSE:HEMO LSE:FAB AQSE:INC LSE:AREC VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
IMM.GB:UK 25I:Germany
Address
One Bartholomew Close, London, GBR, EC1A 7BL
Website
https://www.immupharma.co.uk
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections.

ImmuPharma Headlines

No Headlines